Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients.
CONCLUSION: Psoriatic arthritis appeared significantly associated with subclinical atherosclerosis and endothelial dysfunction and, in turn, with an increased cardiovascular risk. Thus, patients with psoriatic arthritis may benefit from a periodic assessment of surrogate markers of cardiovascular risk. This could help to establish more specific cardiovascular prevention strategies for these patients.
PMID: 29542417 [PubMed - as supplied by publisher]
Source: Reviews on Recent Clinical Trials - Category: Cancer & Oncology Authors: Caso F, Tasso M, Ambrosino P, Nicola M, Di Minno D, Lupoli R, Criscuolo L, Caso P, Ursini F, Puente AD, Scarpa R, Costa L, Peluso R Tags: Rev Recent Clin Trials Source Type: research
More News: Arthritis | Autoimmune Disease | Cancer & Oncology | Cardiology | Cardiovascular | Clinical Trials | Diabetes | Disability | Eating Disorders & Weight Management | Endocrinology | Genetics | Heart | Heart Attack | Hypertension | Metabolic Syndrome | Obesity | Psoriasis | Psoriatic Arthritis | Rheumatology | Skin | Stroke | Thrombosis